Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.
Menu

Crispr Therapeutics Ag (CRSP)

Crispr Therapeutics Ag (CRSP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
FILE - This undated image made available by the National Human Genome Research Institute shows the output from a DNA sequencer. (NHGRI via AP, File)
Studies test whether gene-editing can fix high cholesterol. For now, take your medicine Associated Press - Wed Feb 11, 2:50PM CST

Scientists are testing an entirely new way to fight heart disease: whether gene editing might offer a one-time fix for high cholesterol

CRSP : 54.64 (+2.09%)
Buy enter button by Ardasavasciogullari via iStock
This Leading Gene-Editing Stock Could Be Going Private. Should You Buy Its Shares First? Barchart - Wed Nov 19, 2025

CRISPR Therapeutics is the subject of strong buyout speculation after earning FDA approval for a breakthrough gene-editing therapy.

CRSP : 54.64 (+2.09%)
VRTX : 469.27 (-0.22%)
Healthcare's Shift to Prevention Gains Momentum as Markets Reach Critical Mass BayStreet.ca - Tue Oct 21, 2025

Issued on behalf of Avant Technologies Inc. VANCOUVER – Baystreet.ca News Commentary – Longevity science advances reveal how genes from supercentenarians can reverse cardiac aging[1], while...

HUM : 190.50 (+1.81%)
AVAI : 0.3972 (-0.70%)
CRSP : 54.64 (+2.09%)
VRTX : 469.27 (-0.22%)
MNKD : 5.53 (+1.65%)
Crispr Therapeutics AG (CRSP) Receives a Buy from Citizens JMP Tipranks - Tue Oct 14, 2025

Citizens JMP analyst Silvan Tuerkcan reiterated a Buy rating on Crispr Therapeutics AG today and set a price target of $86.00. The company’s shares closed last Friday at $73.07.Elevate Your Investing...

CRSP : 54.64 (+2.09%)
Truist Financial Sticks to Its Buy Rating for Crispr Therapeutics AG (CRSP) Tipranks - Tue Oct 14, 2025

In a report released today, Joon Lee from Truist Financial maintained a Buy rating on Crispr Therapeutics AG. The company’s shares closed last Friday at $73.07.Elevate Your Investing Strategy: Take advantage...

CRSP : 54.64 (+2.09%)
Global Cell Therapy Market Size Expected to Reach $44 Billion as Demand for Regenerative Medicine Rises FinancialNewsMedia - Thu Sep 18, 2025

EQNX::TICKER_START (OTCQB:AVAI),(NASDAQ:TEM),(NASDAQ:CRSP),(NASDAQ:BNTX),(NYSE:BMY) EQNX::TICKER_END

AVAI : 0.3972 (-0.70%)
CRSP : 54.64 (+2.09%)
TEM : 59.96 (+6.77%)
BNTX : 110.42 (+2.29%)
BMY : 60.30 (+0.95%)
Global Cell Therapy Market Size Expected to Reach $44 Billion as Demand for Regenerative Medicine Rises Newswire.ca - Thu Sep 18, 2025

/CNW/ -- Cell therapy refers to a treatment that involves the use of living cells to treat diseases. The cell therapy market has been experiencing significant...

AVAI : 0.3972 (-0.70%)
CRSP : 54.64 (+2.09%)
TEM : 59.96 (+6.77%)
BNTX : 110.42 (+2.29%)
BMY : 60.30 (+0.95%)
Global Cell Therapy Market Size Expected to Reach $44 Billion as Demand for Regenerative Medicine Rises PR Newswire - Thu Sep 18, 2025

MarketNewsUpdates News Commentary

CRSP : 54.64 (+2.09%)
AVAI : 0.3972 (-0.70%)
TEM : 59.96 (+6.77%)
BNTX : 110.42 (+2.29%)
BMY : 60.30 (+0.95%)
Data Center by Caureem via Shutterstock (2)
This Is How You Can Hedge Your Bets on Tesla Stock and ‘The Largest AI Project on Earth’ Barchart - Fri Sep 12, 2025

Cathie Wood sees Tesla as the largest AI project on Earth, but investors may find steadier upside in her flagship ARKK ETF.

AB : 40.84 (-0.61%)
ROKU : 89.61 (-0.67%)
AAPL : 260.58 (-1.43%)
^ETHUSD : 1,948.616 (+0.06%)
ARKW : 124.45 (+0.67%)
$NASX : 22,682.73 (-0.31%)
$SPX : 6,861.89 (-0.28%)
ARKQ : 126.63 (+2.05%)
COIN : 165.94 (+1.15%)
ARKK : 72.24 (+1.19%)
SHOP : 123.80 (+1.78%)
TSLA : 411.71 (+0.09%)
New Strong Sell Stocks for August 1st
New Strong Sell Stocks for August 1st Zacks Investment Research - Fri Aug 1, 2025

Here are three stocks added to the Zacks Rank #5 (Strong Sell) List today:CRISPR Therapeutics AG CRSP is a gene editing company. The Zacks Consensus Estimate for its current year earnings has been revised...

CRSP : 54.64 (+2.09%)
CSTL : 31.34 (-6.92%)
SIGI : 84.95 (-0.35%)

Barchart Exclusives

Nvidia Dumped Recursion Pharmaceuticals Stock. Should You? Barchart - 1 hour ago
Nvidia sold its position in Recursion Pharmaceuticals, while others keep a measured outlook. Does this divergence signal risk or opportunity? Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot